Thrombosis in conversation
af medthority
Seneste episode
Episode 33: The emotional toll of VTE: A patient’s perspective
Episode 33: The emotional toll of VTE: A patient’s perspective
Om denne podcast
Join expert contributors for this podcast series looking at treatment approaches and clinical challenges in venous thromboembolism (VTE), cancer-associated VTE (CAT) and atrial fibrillation (AF).
Dr Geoffrey Barnes and guests take on gauging the risk of CAT, and guideline recommendations for VTE and CAT; Professor Gregory Lip and Dr Marco Proietti examine real-world evidence for preventing stroke in people with AF.
This podcast is intended for Healthcare Professionals only.
Episoder
De nyeste 20 af 33 episoder
- Episode 33: The emotional toll of VTE: A patient’s perspective · 25 min. · Episode 33“Nobody ever said to me, ‘How are you doing?’ – which I think would have made a big difference.” Dr Barnes welcomes Leslie Lake, VTE survivor and volunteer president of the…
- Episode 32: 2025 breakthroughs in VTE and AF · 27 min. · Episode 32“I am sure 2026 is going to be even more exciting.” Dr Behnood Bikdeli joins Dr Barnes to discuss major advances in VTE and AF management in 2025, including the impact of trials…
- Episode 31: Optimising treatment duration for thrombosis · 26 min. · Episode 31“Just being upfront with patients about those areas of uncertainty can be really helpful…” Dr Deborah Siegal and Dr Barnes break down best practices for balancing safety and…
- Episode 30: VTE and AF at ESC 2025 · 36 min. · Episode 30“I think this was such an important trial, certainly one that has changed my practice already.” Dr Barnes welcomes Dr Marco Proietti for a review and discussion of key studies…
- Episode 29: Individualised care in special populations · 20 min. · Episode 29“We must be patient centred.” Dr Steven Deitelzweig and Dr Barnes address the challenge of balancing bleed risk and thrombosis prevention in special populations, such as those…
- Episode 28: Real-world evidence: Addressing gaps in VTE and AF clinical research · 20 min. · Episode 28What makes good real-world evidence (RWE), and why does it matter? Dr Steven Deitelzweig joins Dr Barnes to discuss how physicians can assess the quality of RWE and its potential…
- Episode 27: A multidisciplinary approach to CAT · 15 min. · Episode 27“As soon as you have a cancer diagnosis, the odds [of VTE] increase 4-fold, 6.5-fold if that particular patient is initiating chemotherapy.” Dr Marc Carrier and Dr Geoffrey…
- Episode 26: From pragmatic trials to everyday treatment – DOACs for CAT · 20 min. · Episode 26Around 50% of patients eligible for anticoagulation treatment do not meet the usual inclusion criteria for randomised controlled trials (RCTs). Dr Marc Carrier joins Dr Barnes…
- Episode 25: AF and CKD – A “tight association” · 23 min. · Episode 25“We have to be careful about who we label with chronic kidney disease.” Dr Piazza returns to talk to Dr Barnes about renal dysfunction in the context of AF, including the factors…
- Episode 24: Clinical considerations: Managing treatment switches · 21 min. · Episode 24Clinical pharmacist Dr Arthur Allen joins Dr Barnes to discuss how to navigate transitions between anticoagulants, including when and why to use bridging low-molecular-weight…
- Episode 23: From hospital to community: Transitions in VTE care · 21 min. · Episode 23Dr Piazza and Dr Barnes discuss how collaboration and a clear message can ease the transition from hospital to home, and the return to daily routines, for people recovering from…
- Episode 22: Selecting anticoagulants: Individualised approaches · 15 min. · Episode 22“We can definitely utilise each other’s strengths and expertise and make some synergy. We all have the same goal here.” Clinical pharmacist Dr Sara Vazquez and Dr Barnes discuss…
- Episode 21: Optimising adherence in anticoagulation therapy · 17 min. · Episode 21Dr Barnes and Dr Sara Vazquez consider the diverse factors that influence patients’ adherence to anticoagulant therapy, including “nuisance bleeding”, pill burden, and whether…
- Episode 20: “If you measure it, you can improve it” – AI for managing AF · 17 min. · Episode 20Artificial intelligence (AI) in cardiovascular care is empowering researchers and clinicians to uncover new findings that were previously undetectable. These data enable more…
- Episode 19: Does obesity positively impact direct oral anticoagulation outcomes? · 21 min. · Episode 19Dr Barnes and Dr Karlyn Martin discuss how recent data have informed opinions on the safety and efficacy of using direct oral anticoagulants (DOAC) in people with obesity and…
- Episode 18: “Can’t I just use an aspirin instead?” · 20 min. · Episode 18Host Dr Geoffrey Barnes and Dr Sara Vazquez review treatment options for stroke prevention in patient groups with AF and discuss overcoming patient and physician barriers to…
- Episode 17: Anticoagulation for atrial fibrillation and comorbid obesity · 21 min. · Episode 17Dr Geoffrey Barnes and Dr Gregory Piazza examine when ongoing weight-adjusted dosages are necessary in a patient with AF and obesity, best practices for monitoring renal function…
- Episode 16: Stroke prevention in AF with high bleeding risk · 22 min. · Episode 16Mitigating the risk of stroke in people with high bleeding risk can be a challenging balancing act. Dr Potpara and Dr Barnes discuss how these risks can be addressed, and how…
- Episode 15: Stroke prevention in older adults with AF · 25 min. · Episode 15Dr Tatjana Potpara and Dr Barnes focus on managing stroke risk in older adults with AF, highlighting the clinical challenge of balancing bleeding risk with the benefits of…
- Episode 14: Wearables: Are they ready for the prime time? · 19 min. · Episode 14Dr Jackson and Dr Barnes take a closer look at the hot topic of wearable devices in AF detection – their potential benefits and limitations – and how physicians can best discuss…
